job News Investors Health professionals Patients Providers Contact TO TO TO IS About Lilly CSR Medicines R&D Lilly Europe Your Health THE DISCOVERY OF NEW DRUGS Accelerating the discovery of innovative drugs that help patients is our main goal. We work to discover and develop innovative medicines that improve current treatment standards and help improve health outcomes for people. Our drugs must demonstrate a positive benefit / risk profile and must represent an advance for the treatment of patients and for professionals working in the Spanish National Health System. One of Lilly's most promising R&D areas is personalized medicine. The ultimate goal, in any case, is to provide the right medicine for the right person, at the right time and in the exact dose. More than 6-500 Lilly employees at its 8 R&D centers and in more than 50 countries strive to make all of this a reality. Investigational Drug Portfolio Lilly currently has an unprecedented number of molecules in clinical development. The company is researching new drugs to offer innovative treatment alternatives for a wide number of diseases, including cancer, multiple sclerosis, diabetes, osteoporosis and Alzheimer's disease among others. Pipeline Lilly's research around the world THE DISCOVERY OF NEW DRUGS PRECLINICAL RESEARCH CLINICAL RESEARCH THE VALUE OF THE DRUG ETHICS AND TRANSPARENCY IN RESEARCH DEVELOPED BY LILLY LILLY AND BIOTECHNOLOGY RESEARCH PROMOTION terms and conditions of use data privacy policy copyright cookies policy site map Copyright © 2019 Eli Lilly and Company. All rights reserved Last Updated: 08/08/19 17:11:20 PP-MG-ES 125

job News Investors Health professionals Patients Providers Contact TO TO TO IS About Lilly CSR Medicines R&D Lilly Europe Your Health INFORMATION FOR HEALTH PROFESSIONALS Portal for healthcare professionals In addition, you can also visit: www.lillydiabetes.es www.lillyoncologia.com www.saladestar.es The information on these sites is designed for the use of healthcare professionals and does not include information directed at patients. Investigational Drug Portfolio Materials for patients Online Conversation If you want to contact a professional from Lilly's Medical Information team online, the icon below should be green. LILLY STANDS OUT IN TRANSPARENCY DONATIONS AND COLLABORATIONS Links of interest Our Medicines terms and conditions of use data privacy policy copyright cookies policy site map Copyright © 2019 Eli Lilly and Company. All rights reserved Last Updated: 11/11/19 21:56:45 PP-MG-ES-0123